China Healthcare Stocks On Recovery Path After $142 Billion Rout
Chinese healthcare stocks are back in vogue after a $142 billion wipeout, as signs grow that the worst
1970-01-01 08:00
China’s Junshi Nabs FDA Approval in Rare Success for US Foray
The US Food and Drug Administration has cleared the first China-developed cancer drug similar to Merck & Co.’s
1970-01-01 08:00
Asian Pharmaceutical Stocks Get Lift From Weight-Loss Drug Hype
Asia took over the baton from Wall Street to see a rally in weight-loss related stocks after a
1970-01-01 08:00